Puri, Sonam
Hyland, Kelly A.
Weiss, Kristine Crowe
Bell, Gillian C.
Gray, Jhanelle E.
Kim, Richard
Lin, Hui-Yi
Hoogland, Aasha I.
Gonzalez, Brian D.
Nelson, Ashley M.
Kinney, Anita Y.
Fischer, Stacy M.
Li, Daneng
Jacobsen, Paul B.
McLeod, Howard L.
Jim, Heather S. L.
Funding for this research was provided by:
National Cancer Institute (P30 CA076292)
Article History
Received: 13 October 2017
Accepted: 20 February 2018
First Online: 15 March 2018
Compliance with ethical standards
: This manuscript describes original work and is not under consideration by any other journal. We have adhered to the journals submission requirements. We have full control of all primary data and we agree to allow the journal to review the data if requested. All authors approve the manuscript and its submission.
: Dr. Li is a consultant for Novartis. Dr. Jim is a consultant for RedHill Biopharma. This work was performed while Dr. Jacobsen was at the Moffitt Cancer Center and does not represent the views of the National Cancer Institute.
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by ant of the authors.
: Informed consent was obtained from all individual participants included in the study.